Company / Tangible Book Value per Share
Nuvation Bio Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.90
FY2025
5-year range
$0.90 / $3769.81
FY2021-FY2025
Trend
-57.3%
vs FY2024
Sector context
#161 of 209
Health Care
What the data says
Nuvation Bio Inc.'s tangible book value per share of $0.90 is lower than 77% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has declined for 4 consecutive years, from $3769.81 in FY2021 to $0.90 in FY2025.
Based on SEC 10-K filings.
0.90 in FY2025 with a 5-year CAGR of -16.3%.
Declined from $2764.63 to $0.90 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -93.3%
- 5-Year CAGR
- -16.3%
- 10-Year CAGR
- -
Sector benchmark
-99.0% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 57.3% year-over-year.
- Ranks #161 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | -57.3% |
| FY2024 | $2.12 | -99.9% |
| FY2023 | $2764.63 | -8.5% |
| FY2022 | $3022.67 | -19.8% |
| FY2021 | $3769.81 | +170842.5% |
| FY2020 | $2.21 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026